An awards ceremony recognized Biopharma firms and service providers that have… SS&C Intralinks Wins Appreciation Award at Korea New Drug Development Awards 8 April 2022
How technology can help institutions automate processes, address today’s… Sanctions, Security and Social Change: The Case for Case Management 7 April 2022
According to the 2022 SS&C Intralinks LP Survey, general partners are… Impact Investing Influencing General Partner-Limited Partner Relationships 4 April 2022
Reviewing strategies, retaining talent are key for success in Q2 2022. For M&A in North America, Adaptation Meets Optimism 24 March 2022
A deep dive into what’s ahead in the market with Benjamin Yeo of Moore… M&A Dealmakers Are Anticipating a Big Year For Middle-Market Dealmaking in ANZ 23 March 2022
Companies are latching on to the global trend in APAC. Outlook for Asia Pacific M&A Dealmaking Is Fueled by ESG 22 March 2022
While deal volume will remain robust, dealmakers need to brace for new… Can Global M&A Surge Past COVID-19 in Q2 2022? 22 March 2022
Get an exclusive preview of global M&A activity in Q2 2022 plus in-depth… Publication SS&C Intralinks Deal Flow Predictor for Q2 2022 18 March 2022
According to our newly published report, Gender Diversity and Dealmaking 2022,… Blog How Female M&A Dealmakers Won the Pandemic 16 March 2022
Five banking scenarios where protecting personally identifiable information (… AI Redaction Can Make or Break a Deal 15 March 2022
Europe-based private equity firm's sweet spot is acquiring firms in "special… A Disciplined M&A Strategy Is the Engine Driving Mutares’ Growth 2 March 2022
What’s ahead for the alternatives industry in the next 18 months? A panel of… Alternatives, Technology and ESG Over the Long Road Ahead 1 March 2022
